Latest Breaking News On - Patrick vermersch - Page 1 : comparemela.com

Study: Frexalimab Shows Sustained Reduction of Disease Activity for Multiple Sclerosis

Frexalimab demonstrated a favorable tolerability profile after approximately 1 year of treatment for individuals with relapsing disease.

Colorado
United-states
France
Denver
American
Patrick-vermersch
Erik-wallstr
American-academy-of-neurology
University-of-lille
American-academy
New-england-journal

The Promise of Frexalimab in MS: Part 3

Patrick Vermersch, MD, PhD, University of Lille, France details the adverse events observed in the frexalimab trials and the next steps necessary to establish frexalimab as a standard of care in multiple sclerosis (MS) in the third and final part of an interview.

United-states
France
American
Patrick-vermersch
University-of-lille
American-academy
New-england-journal

AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease -March 13, 2024 at 08:00 am EDT

PRESS RELEASE NEW RESEARCH SHOWS THAT MASITINIB LIMITS NEURONAL DAMAGE IN A MODEL OF NEUROIMMUNE-DRIVEN NEURODEGENERATIVE DISEASE THIS IS THE FIRST DEMONSTRATION THAT MASITINIB CAN LOWER SERUM.

France
Paris
France-general
Patrick-vermersch
Alain-moussy
University-of-lille
Cold-spring-harbor-laboratory
Euronext-paris
Nfl-biorxiv

Sanofi launches 2 Phase 3 trials to test frexalimab in RRMS, SPMS

Sanofi launches 2 Phase 3 trials to test frexalimab in RRMS, SPMS
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

France
United-states
America
Stephenl-hauser
Patrick-vermersch
University-of-california-san-francisco
University-of-lille
Multiple-sclerosis
New-england-journal
North-america
California-san-francisco
Expanded-disability-status-scale

Sanofi's investigational frexalimab shows promise in relapsing forms of MS

Sanofi's investigational frexalimab shows promise in relapsing forms of MS
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Patrick-vermersch
University-of-lille
New-england-journal